---
title: "PharmaCyte Biotech adds $3 million to its stake in TNF Pharmaceuticals"
url: "https://aibio.space/news/pharmacyte-biotech-adds-3-million-stake-tnf-pharmaceuticals/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2025-09-05"
section: "Mergers"
tickers: "NASDAQ:PMCB"
source: "https://www.sec.gov/Archives/edgar/data/1157075/000168316825006727/pharmacyte_ex9901.htm"
summary: "PharmaCyte says the money is meant to support TNF's license of a light-based computing platform for cryptocurrency mining. TNF plans to change its name and"
---

By the aibio.space news desk.

Sources

- [PharmaCyte Biotech, Inc. 8-K (2025-09-05)](https://www.sec.gov/Archives/edgar/data/1157075/000168316825006727/pharmacyte_ex9901.htm)

[PMCB](https://aibio.space/companies/pharmacyte-biotech/)

2025-09-05

# PharmaCyte Biotech adds $3 million to its stake in TNF Pharmaceuticals

Tickers [PMCB](https://aibio.space/companies/pharmacyte-biotech/)

PharmaCyte says the money is meant to support TNF's license of a light-based computing platform for cryptocurrency mining. TNF plans to change its name and ticker.

## Key facts

- **Company**: PharmaCyte Biotech, Inc. (NASDAQ: PMCB)

- **News type**: Mergers

- **Primary source**: [PharmaCyte Biotech, Inc. 8-K (2025-09-05)](https://www.sec.gov/Archives/edgar/data/1157075/000168316825006727/pharmacyte_ex9901.htm)

*Glass office towers seen from below. CC0, via rawpixel. The picture shows the field, not the companies named.*

PharmaCyte Biotech, Inc. (Nasdaq: [PMCB](https://aibio.space/companies/pharmacyte-biotech/)) said it has increased its stake in TNF Pharmaceuticals (Nasdaq: TNFA) by an additional $3 million.

PharmaCyte said the money is meant to help support TNF's recent license from LightSolver, Ltd. LightSolver makes a processing accelerator that uses light to carry out computations. TNF expects to apply the technology to cryptocurrency mining and blockchain, according to PharmaCyte's [press release](https://www.sec.gov/Archives/edgar/data/1157075/000168316825006727/pharmacyte_ex9901.htm).

TNF is expected to change its name and ticker symbol to fit the new strategy.

PharmaCyte said it remains well-capitalized, with total assets of over $55 million as of April 30, 2025. The company said it continues to evaluate additional opportunities to expand and diversify its investment portfolio.

Among the risks PharmaCyte listed are TNF's ability to use LightSolver's technology in cryptocurrency applications and whether its own search for "new paths toward shareholder value" succeeds.

The press release is dated September 2, 2025, and PharmaCyte filed it with the SEC on September 5, 2025.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

PMCB

PharmaCyte Biotech, Inc.

NASDAQ · United States

Open the starter desk

## More in Mergers

Mergers

### [InMed sets November 5 record date for CVRs tied to Mentari merger](https://aibio.space/news/inmed-sets-november-5-record-date-cvrs-tied-mentari-merger/)

Oct 27, 2026

Mergers

### [Rallybio declares estimated $82.7 million cash distribution tied to Avenzo merger](https://aibio.space/news/rallybio-declares-estimated-82-7-million-cash-distribution-tied-avenzo/)

Oct 26, 2026

Mergers

### [Skye Bioscience files preliminary proxy for its Redx Pharma acquisition](https://aibio.space/news/skye-bioscience-files-preliminary-proxy-redx-pharma-acquisition/)

Oct 26, 2026

---
Source page: https://aibio.space/news/pharmacyte-biotech-adds-3-million-stake-tnf-pharmaceuticals/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "PharmaCyte Biotech adds $3 million to its stake in TNF Pharmaceuticals", 2025-09-05, https://aibio.space/news/pharmacyte-biotech-adds-3-million-stake-tnf-pharmaceuticals/